Compare NVCR & CRAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NVCR | CRAI |
|---|---|---|
| Founded | 2000 | 1965 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.0B |
| IPO Year | 2015 | 1998 |
| Metric | NVCR | CRAI |
|---|---|---|
| Price | $18.38 | $141.39 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 1 |
| Target Price | $28.08 | ★ $245.00 |
| AVG Volume (30 Days) | ★ 1.7M | 148.6K |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 1.48% |
| EPS Growth | ★ 21.79 | 20.77 |
| EPS | N/A | ★ 8.14 |
| Revenue | $655,353,000.00 | ★ $751,583,000.00 |
| Revenue This Year | $7.72 | $7.82 |
| Revenue Next Year | $6.74 | $5.14 |
| P/E Ratio | ★ N/A | $17.83 |
| Revenue Growth | 8.28 | ★ 9.33 |
| 52 Week Low | $9.82 | $134.47 |
| 52 Week High | $20.05 | $227.29 |
| Indicator | NVCR | CRAI |
|---|---|---|
| Relative Strength Index (RSI) | 75.89 | 35.98 |
| Support Level | $12.66 | N/A |
| Resistance Level | N/A | $166.99 |
| Average True Range (ATR) | 0.99 | 7.93 |
| MACD | 0.48 | -1.43 |
| Stochastic Oscillator | 93.91 | 20.69 |
NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.
CRA International Inc is a consulting firm specializing in providing economic, financial and management consulting services. The company provides advisory services on economic and financial matters related to litigation and regulatory proceedings, and advises corporations on business and performance-related matters. Its consulting services are organized into two areas: litigation, regulatory and financial consulting, and management consulting. The company's clients include domestic and foreign companies, government agencies, public and private utilities, and national and international trade associations. It derives revenues by providing professional and consulting services. Geographically, the maximum revenue is derived from the United States, followed by United Kingdom and other regions.